Comparative Pharmacology
Head-to-head clinical analysis: CORDRAN N versus SATRIC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CORDRAN N versus SATRIC.
CORDRAN N vs SATRIC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cordran N contains flurandrenolide, a corticosteroid that exerts anti-inflammatory, antipruritic, and vasoconstrictive actions by inducing phospholipase A2 inhibitory proteins (lipocortins) and modulating gene expression; neomycin is an aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit.
SATRIC is a combination of sulfathiazole, sulfacetamide, and sulfabenzamide, which are sulfonamide antibiotics. They competitively inhibit dihydropteroate synthase, blocking folate synthesis in susceptible bacteria.
Apply sparingly to affected area 2-3 times daily. Use for no longer than 2 weeks.
No standard dosing information available for SATRIC.
None Documented
None Documented
Approximately 1-2 hours. Short half-life consistent with topical use; systemic exposure minimal with proper application.
3-5 hours in healthy adults; prolonged to 6-8 hours in renal impairment (CrCl < 30 mL/min)
Primarily renal (biliary/fecal minimal). Unchanged drug and glucuronide metabolites excreted in urine.
Renal: 70% unchanged; fecal: 20%; biliary: 10%
Category C
Category C
Topical Corticosteroid + Antibiotic
Antiprotozoal, Antibiotic